Santa Clara, CO, United States of America

Christopher K Savile

USPTO Granted Patents = 35 

 

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 138(Granted Patents)


Location History:

  • Sunnyvale, CA (US) (2012 - 2014)
  • Redwood City, CA (US) (2014)
  • Santa Clara, CO (US) (2019)
  • Santa Clara, CA (US) (2014 - 2022)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
35 patents (USPTO):

Title: Christopher K. Savile: Innovator in Biocatalysis and Chiral Compound Synthesis

Introduction: Christopher K. Savile is a prominent inventor based in Santa Clara, Colorado, known for his significant contributions to the field of biocatalysis. With an impressive portfolio of 31 patents, Savile has been at the forefront of developing engineered enzymes that possess improved properties for various applications in biotechnology.

Latest Patents: Among his latest achievements, Savile has worked on engineered ketoreductase polypeptides. These innovations focus on enhancing the properties of ketoreductase enzymes compared to their naturally occurring wild-type counterparts. His work includes polynucleotides that encode these engineered enzymes, alongside host cells capable of expressing them. A notable application of this technology is in synthesizing chiral compounds, such as converting N-methyl-3-keto-3-(2-thienyl)-1-propanamine to (S)-N-methyl-3-hydroxy-3-(2-thienyl)-1-propanamine. Additionally, he has explored transaminase reactions, contributing to methods that utilize transaminase polypeptides for synthesizing chiral amines from prochiral ketones.

Career Highlights: Christopher K. Savile has made a significant impact in the biotechnology sector through his role at Codexis, Inc. His innovations have been pivotal in advancing biocatalysis, making him a key figure in the development of efficient and sustainable chemical processes.

Collaborations: During his career, Savile has collaborated with renowned colleagues such as Emily Mundorff and Gjalt W. Huisman. These partnerships have resulted in groundbreaking advancements within the field, further highlighting the collaborative spirit that drives innovation in scientific research.

Conclusion: Christopher K. Savile continues to be a leading inventor in the biocatalysis domain. His extensive patent portfolio underscores his commitment to enhancing enzyme technology for effective chiral synthesis, evidencing the importance of his contributions to the field and the broader implications for biotechnology advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…